List of AI therapeutics companies

Zymergen, founded in 2013 and located in Emeryville, California, is a technology company providing organisms engineering services. Their biotechnology labs rely on advanced manufacturing technologies, machine learning techniques, and genomics to accelerate the design, build, test cycle of microorganisms.

Insilico Medicine is a drug discovery, artificial intelligence company that looks to treat cancer and age related diseases

SymphonyAI is an enterprise AI software company focused on applications for specific vertical use cases in retail, CPG, financial, manufacturing, media, IT and public sector. The company was founded in 2017 by Romesh Wadhwani and is based in Palo Alto, CA.

Recursion Pharmaceuticals is a biotechnology and data science company based in Salt Lake City, Utah, founded in 2013, that combines biology with artificial intelligence for drug discovery. Using human cell models of diseases, Recursion captures microscopic images to build biological datasets and computational techniques identify disease-associated.

Notable Labs is a company providing personalized drug combination testing service for cancer patients.

Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.

ApexQubit is a biotechnology company that is harnessing a proprietary technology for discovery of new medicines to treat patients with undruggable diseases.

Envisagenics is a biotechnology company founded by Maria Luisa Pineda and Martin Akerman in 2014 and headquartered in New York City, New York using artificial intelligence and RNA sequencing to develop therapeutics to treat genetic diseases.

A therapeutics company founded in 2016 working in drug discovery and development using fungi. LifeMine uses genomics approaches to search for biosynthetic genes in eukaryotic microbes for the discovery of naturally inspired drugs to treat previously untreatable and significant chronic diseases.

A bioinformatics company in San Francisco building data collection methods and databases that will enable machine learning algorithms in healthcare. It was founded in 2018.

Faeth Therapeutics is a start-up that focuses on using nutrition and metabolism to fight cancer.

Dyno Therapeutics is a company based in Cambridge, Massachusetts applying artificial intelligence to gene therapy, focused on adeno-associated virus capsid engineering.

Peptome is a London-based protein physics intelligence company founded in 2016 by Kamil Tamiola and Matt Heberling. It utilizes artificial intelligence for computers to process all information about protein data in the same efficient way that scientists do.

Biofourmis is a global health IT start-up in Massachusetts that focuses on personalized care and therapies using digital therapeutics.

Buoy is an AI-driven digital assistant that helps patients self-diagnose and triage to the appropriate care.

Tata Elxsi is a design and technology company.

Stelvio Therapeutics is a biotechnology company developing therapeutics for cancer.

A biotechnology company applying AI and genomics to precision medicine to address patient subpopulations that have unmet needs. Their pipeline of drug candidates address cancer, neurology, inflammation, infectious disease and metabolic disease. It is located in Palo Alto, California and was founded in 2014.

Gritstone Oncology is a Emeryville, California-based biotechnology company developing neoantigen-specific cancer immunotherapies.

Juvenescence is an AI-driven drug discovery platform founded in 2016 by Jim Mellon, Declan Doogan and Greg Bailey.

AI-powered CBT therapeutic platform.

Palo Alto, California-based Limbix is not your average virtual reality startup: It makes a software that therapists use in what's called "exposure therapy," simulating stressful or trauma-inducing situations for patients to help them overcome their fears.

A company using quantum computing and machine learning to design proteins.

Loop Therapeutics is a biotechnology and pharmaceutical company that was founded in 2014 by Hugo Peris and headquartered in San Francisco, California developing pharmaceutical products to treat corneal diseases.

SF17 Therapeutics is a company founded in 2018 and based in Berkeley, California, that uses analytics and AI to develop precision immune therapies to target autoimmune, auto-inflammatory disease and immune oncology conditions.